Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 70 5
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
TPNT1 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/22/2021 1 0
Baicalein Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 6 0
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Apabetalone Potential treatment - pre-clinical evidence Experimental Antiviral Apr/18/2021 2 0
L-Carnitine Potential treatment - pre-clinical evidence Natural product Antiviral Apr/14/2021 1 0
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 5 0